tiprankstipranks
Trending News
More News >
Claritas Pharmaceuticals (CLAZF)
OTHER OTC:CLAZF
US Market

Claritas Pharmaceuticals (CLAZF) Income Statement

Compare
24 Followers

Claritas Pharmaceuticals Income Statement

Last quarter (Q3 2021), Claritas Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Claritas Pharmaceuticals's net income was $181.00K. See Claritas Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ -184.00K$ 9.45M$ 11.10M$ 5.09M
Depreciation and Amortization
$ -184.00K$ 9.45M$ 11.10M$ 19.00K
EBITDA
$ -2.79M$ -16.72M$ 18.14M$ -15.44M
Operating Income
$ -3.28M$ -9.45M$ -11.10M$ -14.50M
Other Income/Expenses
$ 3.25M$ -16.13M$ 17.94M$ -17.36M
Pretax Income
$ -674.00K$ -25.83M$ 6.84M$ -31.86M
Net Income
$ 4.21M$ -21.21M$ 6.93M$ -31.86M
Per Share Metrics
Basic EPS
$ 0.16$ -0.95$ 0.55$ -5.20
Diluted EPS
$ 0.16$ -1.00$ 0.64$ -5.20
Weighted Average Shares Outstanding
26.69M 22.44M 12.52M 6.21M
Weighted Average Shares Outstanding (Diluted)
26.69M 22.44M 10.92M 6.21M
Currency in USD

Claritas Pharmaceuticals Earnings and Revenue History